We bring specialised legal expertise across technology regulatory regimes that commonly affect VC portfolios and transaction targets, including:

• Artificial intelligence. Regulatory risk tied to AI governance, transparency, safety and obligations under emerging AI rules.
• Intellectual property (IP). Ownership, IP assignments, licensing risks and trade secrets.
• Antitrust / Competition law. Merger control, cartel risk, distribution and technology transfer practices, and unilateral conduct exposure.
• Privacy & data protection. GDPR, ePrivacy and industry-specific data obligations.
• Blockchain & crypto. Token classification, custody, AML obligations and regulatory licensing risk.
• Medical devices & regulated health products. Product classification, regulatory approvals, clinical-data governance and post-market obligations.
• EU digital rulebooks: Including the Digital Markets Act, Digital Services Act and the EU Data Act, and their implications for platform behaviour, data access, intermediary liability and cross-border data flows.

In the rush to build products, hit growth metrics, and close funding rounds, many start-ups and scale-ups deprioritise basic compliance and governance items, leaving regulatory gaps that are invisible until they become expensive.

Left unchecked, these gaps lead to a spectrum of preventable harms, such as:

• regulatory investigations and penalties,
• injunctions that delay or block transactions,
• expensive remediation,
• unexpected liabilities for indemnities, and
• reputational damage to both the portfolio company and its investors.

For a VC firm, those harms translate directly into:

• diminished enterprise value,
• erosion of limited partners’ trust,
• difficulties in exit processes, and
• increased deal friction (longer diligence cycles, tougher warranty negotiations, escrow demands and price adjustments).